Evidence map›Paper›PMID 35540133›Full record

ReviewRSC advances2018

Acyclic and cyclic imines and their metal complexes: recent progress in biomaterials and corrosion applications.

Wail Al Zoubi, Saad Gomaa Mohamed, Abbas Ali Salih Al-Hamdani, Agastya Prastita Mahendradhany, Young Gun Ko

Abstract readReview
In one paragraph

Review in RSC advances, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Corrosion inhibition andRSC advances · 2025
    Article
  2. Review
  3. GαCancers · 2024
    Article
  4. Article
  5. Tandem imine formationRSC advances · 2021
    Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Wail Al ZoubiMaterials Electrochemistry Group, School of Materials Science and Engineering, Yeungnam University Gyeongsan 38541 Republic of Korea wailalzoubi@ynu.ac.kr younggun@ynu.ac.kr.ORCID https://orcid.org/0000-0003-4213-8481
Saad Gomaa MohamedMining and Metallurgy Engineering Department, Tabbin Institute for Metallurgical Studies (TIMS) Tabbin Helwan 109 Cairo 11421 Egypt.ORCID https://orcid.org/0000-0001-7465-4582
Abbas Ali Salih Al-HamdaniDepartment of Chemistry, College of Science for Women University of Baghdad Baghdad Iraq.
Agastya Prastita MahendradhanyMaterials Electrochemistry Group, School of Materials Science and Engineering, Yeungnam University Gyeongsan 38541 Republic of Korea wailalzoubi@ynu.ac.kr younggun@ynu.ac.kr.
Young Gun KoMaterials Electrochemistry Group, School of Materials Science and Engineering, Yeungnam University Gyeongsan 38541 Republic of Korea wailalzoubi@ynu.ac.kr younggun@ynu.ac.kr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This review describes the contemporary development applications on scientific areas of acyclic and cyclic Schiff bases and their complexes with an emphasis on the author's contribution to the field. After a short historical introduction, this manuscript is divided into two main parts. In the first section, Schiff bases are reviewed for their biological activities including antibacterial, antifungal, antioxidant, cytotoxic, and enzymatic activities as well as their interaction with single-stranded-DNA which have shown remarkable activities in each region of research. The second part deals with the corrosion of metal and its alloys in corrosive environments and their organic inhibitors. The main section of this part is to investigate the different chemical structures for Schiff bases used in such aggressive solution to protect metals. Knowing the maximum corrosion efficiency or bioactivity of a specific chemical structure in a specific application environment is helpful for choosing the most appropriate compound.

Identifiers

PMID35540133
PMCPMC9081553

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.